example alt text

News

Archive

Previous news can be viewed below.

News

Nov 07 Investing for Growth
(www.investing-for-growth.co.uk)
Nov 07 Growth Company Investor
Jun 07 Investing for Growth
(www.investing-for-growth.co.uk)
Apr 07 Investing for Growth
(www.investing-for-growth.co.uk)
Apr 07 Sunday Times
Sep 06 Peter Shearlock's Small Cap Stock Picks
Jan 06 Share Purchase by Director

 

RNS Announcements

27/07/10 Result of AGM
27/07/10 AGM Statement
27/07/10 AGM Statement
02/07/10 Posting of Annual Report and Notice of AGM
02/06/10 Preliminary Results
21/04/10 Close Period Trading Update
22/03/10 Sale of Volplex and Isoplex
04/03/10 IS Pharma acquires exclusive European rights for Episil®
11/01/10 IS Pharma granted exclusive license and supply rights for Aequasyal® (oxidised glycerol triester) in the UK
23/11/09 Variquel® (Haemopressin®) Update
11/11/09 Notice of Interim Results for the six months ended 30 September 2009
10/11/09 Notification of Major Interests in Shares
01/10/09 Pre‐Close Statement
01/09/09 Repurchase of Deferred Ordinary Shares
07/08/09 Director Shareholding
31/07/09 AGM Statement
31/07/09 Result of AGM
31/07/09 Committee membership
28/07/09 Audit and Remuneration Committee Membership Final
28/07/09 Result of AGM
06/07/09 Annual Reports and Accounts and Notice of AGM
30/06/09
30/06/09 Total Voting Rights
22/06/09 Launch of Variquel™ (Haemopressin®)
18/06/09 FDA accepts final section of NDA filing for Lucassin
03/06/09 Preliminary Results
21/05/09 Change of Nominated Adviser and Broker
13/05/09 Preliminary Results Announcement
07/05/09 Directorate appointment
16/03/09 Haemopressin MRP Announcement
13/01/09 Directorate changes
03/11/08 Isoplex Launch
14/10/08 Notice of Interim Results
12/09/08 Result of AGM 2008
10/09/08 AGM Statement 2008
03/09/08 US Commercialisation Partner for Haemopressin
03/09/08 Trading Update
18/08/08 Notice of AGM
15/08/08 Notification of Interest
31/07/08 Grant of Options
03/06/08 Preliminary results for the year ended 31 March 2008
30/05/08 Cancellation of Share Premium Account
29/05/08 Notification of Results
22/05/08 Notification of interest
06/05/08 Notification of Interest
02/05/08 Notification of Interest
30/04/08 Notification of Interest
28/04/08 Completion of Acquisition Speciality European Pharma International AG
22/04/08 Directors Dealings
22/04/08 Consolidation and Placing
21/04/08 Result of General Meeting
28/03/08 Acquisition of Speciality European Pharma International AG
11/02/08 Aloxi Launch
13/12/07 Notification of Interest
23/11/07 Investing for Growth
(www.investing-for-growth.co.uk)
13/11/07 Growth Company Investor
06/11/07 Interim results - Maelor transformed to deliver results ahead of expectations
06/11/07 Chief Executive stock purchase
31/10/07 New Distribution Agreement
29/10/07 Aloxi® License Agreement
25/10/07 Notice of Interim Results
25/10/07 Notice of Interim Results
17/09/07 Annual Report and Accounts
05/09/07 Result of AGM
05/09/07 AGM Statement
15/08/07 Rule 26 Compliance
10/08/07 Notice of AGM
10/08/07 Notification of Interest
28/06/07 Change of accounting reference date
22/06/07 Launch of Variquel™ (Haemopressin®)
18/06/07 Investing for Growth
(www.investing-for-growth.co.uk)
05/06/07 Maelor results ahead of expectations - profitable in H2
25/05/07 Notification of Interest
22/05/07 Director dealings
22/05/07 Notice of Results
11/05/07 Notification of interest
11/05/07 Notification of interest
10/05/07 Acquisition of Acorus Therapeutics Ltd completed
10/05/07 Director dealings
08/05/07 Director dealings
08/05/07 Re-Admission, Conditional Placing and Acquisition
04/05/07 Result of EGM
20/04/07 Notification of Interest
19/04/07 Maelor PLC - Holding(s) in Company
10/04/07 AIM - Schedule 1 - Maelor plc
05/04/07 Change of Adviser
05/04/07 Acquisition of Acorus Therapeutics Ltd
05/04/07 Pre-Close Statement and Trading update
01/04/07 Investing for Growth
(www.investing-for-growth.co.uk)
01/04/07 Sunday Times
05/03/07 Change of address of Registered Office
22/12/06 Total Voting Rights and Share Capital
19/12/06 Issue of Equity
24/11/06 Interim Report 2006
02/11/06 Interim Results
01/11/06 Appointment of nominated adviser and broker
20/10/06 Notice of Results
14/09/06 Director Dealings
12/09/06 Director Dealings
01/09/06 Peter Shearlock's Small Cap Stock Picks
30/08/06 Grant of Options
02/08/06 AGM Statement
11/07/06 Year End Accounts
01/06/06 Preliminary Results and Strategic Review
01/06/06 Maelor and Plethora Solutions enter into a licensing agreement for micelle nanotechnology
01/06/06 Appointment of new Finance Director
23/02/06 Share Price Announcement
31/01/06 Share Purchase by Director
30/11/05 EGM Results
22/10/05 Interim Accounts
05/10/05 Appointment of new Chief Executive
27/07/05 Annual General Meeting Statement and Acquisition of Product Rights
19/07/05 Maelor Announces Launch of ContiSol® in Canada, and Appointment of Exclusive Volplex® Distributor in Greece and the Balkans
25/05/05 Maelor plc Preliminary Results
28/04/05 Maelor plc Appoints Geoffrey McMillan as Non-Executive Director
19/04/05 Maelor plc - Appoints AAM Inc. as exclusive ContiSol™ distributors for Canada and the USA
16/12/04 New Nominated Advisor Appointed
01/12/04 Directorate
03/11/04 Maelor plc - Interim Results
28/07/04 Maelor plc Announces New Board Appointment
27/07/04 AGM Statement
21/07/04 Maelor Appoints Volplex® Distributor for South Korea
02/06/04 Maelor plc - Preliminary Results
20/05/04 Maelor plc Granted Regulatory Approval for ContiSol™ in Canada
10/05/04 Announcement
15/04/04 Board Statement
30/03/04 Maelor Signs Micelle Technology Agreement
20/03/04 Maelor Receives Volplex® Regulatory Approval
24/02/04 Maelor signs significant contract for Volplex® in China
18/08/02 FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN®